The 23-Valent Pneumococcal Polysaccharide Vaccine. Part II. A Cost-Effectiveness Analysis for Invasive Disease in the Elderly in England and Wales

By Melegaro Alessia   Edmunds W. John  

European Journal of Epidemiology, Vol. 19, Iss. 4, 2004-04 ,pp. : 365-375

Springer Publishing Company

Access to resources Recommend Favorite

Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia

By Torling J.   Hedlund J.   Konradsen H.B.   Ortqvist A.  

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 96-103

Elsevier

Access to resources Recommend Favorite

Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection

By Hoan-Jong L.   Jin-Han K.   Henrichsen J.   Konradsen H.B.   Seong-Hee J.   Hee-Young S.   Hyo-Seop A.   Yong C.   Hessel L.   Sung-Woo N.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1533-1538

Elsevier

Access to resources Recommend Favorite

Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials

By Cornu C.   Yzebe D.   Leophonte P.   Gaillat J.   Boissel J.P.   Cucherat M.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4780-4790

Elsevier

Access to resources Recommend Favorite

Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults

By Feikin D.R.   Elie C.M.   Goetz M.B.   Lennox J.L.   Carlone G.M.   Romero-Steiner S.   Holder P.F.   O'Brien W.A.   Whitney C.G.   Butler J.C.   Breiman R.F.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 545-553

Elsevier

Access to resources Recommend Favorite